nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefdinir—Interstitial pneumonia—Auranofin—psoriatic arthritis	0.0513	0.0513	CcSEcCtD
Cefdinir—Interstitial lung disease—Auranofin—psoriatic arthritis	0.035	0.035	CcSEcCtD
Cefdinir—Hepatitis acute—Methotrexate—psoriatic arthritis	0.0331	0.0331	CcSEcCtD
Cefdinir—Melaena—Auranofin—psoriatic arthritis	0.0242	0.0242	CcSEcCtD
Cefdinir—Aplastic anaemia—Auranofin—psoriatic arthritis	0.0233	0.0233	CcSEcCtD
Cefdinir—Dermatitis exfoliative—Auranofin—psoriatic arthritis	0.0191	0.0191	CcSEcCtD
Cefdinir—Allergic cutaneous angiitis—Methotrexate—psoriatic arthritis	0.0151	0.0151	CcSEcCtD
Cefdinir—Pancytopenia—Auranofin—psoriatic arthritis	0.0148	0.0148	CcSEcCtD
Cefdinir—Neutropenia—Auranofin—psoriatic arthritis	0.0145	0.0145	CcSEcCtD
Cefdinir—Stomatitis—Auranofin—psoriatic arthritis	0.0135	0.0135	CcSEcCtD
Cefdinir—Jaundice—Auranofin—psoriatic arthritis	0.0135	0.0135	CcSEcCtD
Cefdinir—Conjunctivitis—Auranofin—psoriatic arthritis	0.0135	0.0135	CcSEcCtD
Cefdinir—Haematuria—Auranofin—psoriatic arthritis	0.0132	0.0132	CcSEcCtD
Cefdinir—Agranulocytosis—Auranofin—psoriatic arthritis	0.0129	0.0129	CcSEcCtD
Cefdinir—Peptic ulcer—Prednisolone—psoriatic arthritis	0.0118	0.0118	CcSEcCtD
Cefdinir—Peptic ulcer—Triamcinolone—psoriatic arthritis	0.0109	0.0109	CcSEcCtD
Cefdinir—Peptic ulcer—Methylprednisolone—psoriatic arthritis	0.0108	0.0108	CcSEcCtD
Cefdinir—Flatulence—Auranofin—psoriatic arthritis	0.0107	0.0107	CcSEcCtD
Cefdinir—Nephropathy—Methotrexate—psoriatic arthritis	0.0101	0.0101	CcSEcCtD
Cefdinir—Interstitial pneumonia—Methotrexate—psoriatic arthritis	0.00993	0.00993	CcSEcCtD
Cefdinir—Peptic ulcer—Betamethasone—psoriatic arthritis	0.00987	0.00987	CcSEcCtD
Cefdinir—Peptic ulcer—Dexamethasone—psoriatic arthritis	0.00987	0.00987	CcSEcCtD
Cefdinir—Leukocytoclastic vasculitis—Methotrexate—psoriatic arthritis	0.00979	0.00979	CcSEcCtD
Cefdinir—Leukopenia—Auranofin—psoriatic arthritis	0.0097	0.0097	CcSEcCtD
Cefdinir—Thrombocytopenia—Auranofin—psoriatic arthritis	0.00866	0.00866	CcSEcCtD
Cefdinir—Peptic ulcer—Prednisone—psoriatic arthritis	0.00859	0.00859	CcSEcCtD
Cefdinir—Anorexia—Auranofin—psoriatic arthritis	0.00843	0.00843	CcSEcCtD
Cefdinir—Vaginal discharge—Methotrexate—psoriatic arthritis	0.00789	0.00789	CcSEcCtD
Cefdinir—Dyspepsia—Auranofin—psoriatic arthritis	0.00779	0.00779	CcSEcCtD
Cefdinir—Decreased appetite—Auranofin—psoriatic arthritis	0.00769	0.00769	CcSEcCtD
Cefdinir—Constipation—Auranofin—psoriatic arthritis	0.00756	0.00756	CcSEcCtD
Cefdinir—Gastrointestinal pain—Auranofin—psoriatic arthritis	0.00723	0.00723	CcSEcCtD
Cefdinir—Abdominal pain—Auranofin—psoriatic arthritis	0.00699	0.00699	CcSEcCtD
Cefdinir—Candida infection—Triamcinolone—psoriatic arthritis	0.00694	0.00694	CcSEcCtD
Cefdinir—Interstitial lung disease—Methotrexate—psoriatic arthritis	0.00678	0.00678	CcSEcCtD
Cefdinir—Pruritus—Auranofin—psoriatic arthritis	0.00626	0.00626	CcSEcCtD
Cefdinir—Diarrhoea—Auranofin—psoriatic arthritis	0.00605	0.00605	CcSEcCtD
Cefdinir—Vomiting—Auranofin—psoriatic arthritis	0.00562	0.00562	CcSEcCtD
Cefdinir—Rash—Auranofin—psoriatic arthritis	0.00558	0.00558	CcSEcCtD
Cefdinir—Dermatitis—Auranofin—psoriatic arthritis	0.00557	0.00557	CcSEcCtD
Cefdinir—Purpura—Triamcinolone—psoriatic arthritis	0.00547	0.00547	CcSEcCtD
Cefdinir—Cardiac failure—Methylprednisolone—psoriatic arthritis	0.00539	0.00539	CcSEcCtD
Cefdinir—Nausea—Auranofin—psoriatic arthritis	0.00525	0.00525	CcSEcCtD
Cefdinir—Hyperkinesia—Prednisone—psoriatic arthritis	0.00501	0.00501	CcSEcCtD
Cefdinir—Cardiac failure—Dexamethasone—psoriatic arthritis	0.00491	0.00491	CcSEcCtD
Cefdinir—Cardiac failure—Betamethasone—psoriatic arthritis	0.00491	0.00491	CcSEcCtD
Cefdinir—Vaginal inflammation—Methotrexate—psoriatic arthritis	0.0048	0.0048	CcSEcCtD
Cefdinir—Melaena—Methotrexate—psoriatic arthritis	0.00469	0.00469	CcSEcCtD
Cefdinir—Asthma—Triamcinolone—psoriatic arthritis	0.00456	0.00456	CcSEcCtD
Cefdinir—Vaginal infection—Methotrexate—psoriatic arthritis	0.00453	0.00453	CcSEcCtD
Cefdinir—Aplastic anaemia—Methotrexate—psoriatic arthritis	0.00451	0.00451	CcSEcCtD
Cefdinir—Acute coronary syndrome—Prednisolone—psoriatic arthritis	0.00436	0.00436	CcSEcCtD
Cefdinir—Myocardial infarction—Prednisolone—psoriatic arthritis	0.00433	0.00433	CcSEcCtD
Cefdinir—Purpura—Prednisone—psoriatic arthritis	0.00433	0.00433	CcSEcCtD
Cefdinir—Conjunctivitis—Prednisolone—psoriatic arthritis	0.0043	0.0043	CcSEcCtD
Cefdinir—Cardiac failure—Prednisone—psoriatic arthritis	0.00427	0.00427	CcSEcCtD
Cefdinir—Acute coronary syndrome—Triamcinolone—psoriatic arthritis	0.00401	0.00401	CcSEcCtD
Cefdinir—Acute coronary syndrome—Methylprednisolone—psoriatic arthritis	0.004	0.004	CcSEcCtD
Cefdinir—Haemoglobin—Prednisolone—psoriatic arthritis	0.00399	0.00399	CcSEcCtD
Cefdinir—Myocardial infarction—Triamcinolone—psoriatic arthritis	0.00399	0.00399	CcSEcCtD
Cefdinir—Myocardial infarction—Methylprednisolone—psoriatic arthritis	0.00398	0.00398	CcSEcCtD
Cefdinir—Haemorrhage—Prednisolone—psoriatic arthritis	0.00397	0.00397	CcSEcCtD
Cefdinir—Conjunctivitis—Triamcinolone—psoriatic arthritis	0.00395	0.00395	CcSEcCtD
Cefdinir—Hepatic failure—Methotrexate—psoriatic arthritis	0.00388	0.00388	CcSEcCtD
Cefdinir—Renal failure acute—Methotrexate—psoriatic arthritis	0.00377	0.00377	CcSEcCtD
Cefdinir—Dermatitis exfoliative—Methotrexate—psoriatic arthritis	0.00369	0.00369	CcSEcCtD
Cefdinir—Haemoglobin—Triamcinolone—psoriatic arthritis	0.00367	0.00367	CcSEcCtD
Cefdinir—Haemoglobin—Methylprednisolone—psoriatic arthritis	0.00366	0.00366	CcSEcCtD
Cefdinir—Haemorrhage—Triamcinolone—psoriatic arthritis	0.00365	0.00365	CcSEcCtD
Cefdinir—Haemorrhage—Methylprednisolone—psoriatic arthritis	0.00364	0.00364	CcSEcCtD
Cefdinir—Acute coronary syndrome—Dexamethasone—psoriatic arthritis	0.00364	0.00364	CcSEcCtD
Cefdinir—Acute coronary syndrome—Betamethasone—psoriatic arthritis	0.00364	0.00364	CcSEcCtD
Cefdinir—Myocardial infarction—Betamethasone—psoriatic arthritis	0.00362	0.00362	CcSEcCtD
Cefdinir—Myocardial infarction—Dexamethasone—psoriatic arthritis	0.00362	0.00362	CcSEcCtD
Cefdinir—Conjunctivitis—Dexamethasone—psoriatic arthritis	0.00359	0.00359	CcSEcCtD
Cefdinir—Conjunctivitis—Betamethasone—psoriatic arthritis	0.00359	0.00359	CcSEcCtD
Cefdinir—Neutropenia—Prednisone—psoriatic arthritis	0.00337	0.00337	CcSEcCtD
Cefdinir—Haemoglobin—Betamethasone—psoriatic arthritis	0.00333	0.00333	CcSEcCtD
Cefdinir—Haemoglobin—Dexamethasone—psoriatic arthritis	0.00333	0.00333	CcSEcCtD
Cefdinir—Haemorrhage—Dexamethasone—psoriatic arthritis	0.00331	0.00331	CcSEcCtD
Cefdinir—Haemorrhage—Betamethasone—psoriatic arthritis	0.00331	0.00331	CcSEcCtD
Cefdinir—Acute coronary syndrome—Prednisone—psoriatic arthritis	0.00317	0.00317	CcSEcCtD
Cefdinir—Myocardial infarction—Prednisone—psoriatic arthritis	0.00315	0.00315	CcSEcCtD
Cefdinir—Toxic epidermal necrolysis—Methotrexate—psoriatic arthritis	0.00314	0.00314	CcSEcCtD
Cefdinir—Loss of consciousness—Prednisolone—psoriatic arthritis	0.00304	0.00304	CcSEcCtD
Cefdinir—Asthma—Methotrexate—psoriatic arthritis	0.00301	0.00301	CcSEcCtD
Cefdinir—Convulsion—Prednisolone—psoriatic arthritis	0.00299	0.00299	CcSEcCtD
Cefdinir—Hypertension—Prednisolone—psoriatic arthritis	0.00298	0.00298	CcSEcCtD
Cefdinir—Haemoglobin—Prednisone—psoriatic arthritis	0.0029	0.0029	CcSEcCtD
Cefdinir—Haemorrhage—Prednisone—psoriatic arthritis	0.00288	0.00288	CcSEcCtD
Cefdinir—Pancytopenia—Methotrexate—psoriatic arthritis	0.00286	0.00286	CcSEcCtD
Cefdinir—Anaphylactic shock—Prednisolone—psoriatic arthritis	0.00282	0.00282	CcSEcCtD
Cefdinir—Neutropenia—Methotrexate—psoriatic arthritis	0.00282	0.00282	CcSEcCtD
Cefdinir—Loss of consciousness—Triamcinolone—psoriatic arthritis	0.00279	0.00279	CcSEcCtD
Cefdinir—Loss of consciousness—Methylprednisolone—psoriatic arthritis	0.00279	0.00279	CcSEcCtD
Cefdinir—Shock—Prednisolone—psoriatic arthritis	0.00277	0.00277	CcSEcCtD
Cefdinir—Convulsion—Triamcinolone—psoriatic arthritis	0.00275	0.00275	CcSEcCtD
Cefdinir—Convulsion—Methylprednisolone—psoriatic arthritis	0.00275	0.00275	CcSEcCtD
Cefdinir—Hypertension—Triamcinolone—psoriatic arthritis	0.00274	0.00274	CcSEcCtD
Cefdinir—Hypertension—Methylprednisolone—psoriatic arthritis	0.00274	0.00274	CcSEcCtD
Cefdinir—Pneumonia—Methotrexate—psoriatic arthritis	0.0027	0.0027	CcSEcCtD
Cefdinir—Stevens-Johnson syndrome—Methotrexate—psoriatic arthritis	0.00266	0.00266	CcSEcCtD
Cefdinir—Dry mouth—Triamcinolone—psoriatic arthritis	0.00265	0.00265	CcSEcCtD
Cefdinir—Renal failure—Methotrexate—psoriatic arthritis	0.00264	0.00264	CcSEcCtD
Cefdinir—Stomatitis—Methotrexate—psoriatic arthritis	0.00262	0.00262	CcSEcCtD
Cefdinir—Conjunctivitis—Methotrexate—psoriatic arthritis	0.00261	0.00261	CcSEcCtD
Cefdinir—Anaphylactic shock—Triamcinolone—psoriatic arthritis	0.00259	0.00259	CcSEcCtD
Cefdinir—Anaphylactic shock—Methylprednisolone—psoriatic arthritis	0.00259	0.00259	CcSEcCtD
Cefdinir—Haematuria—Methotrexate—psoriatic arthritis	0.00256	0.00256	CcSEcCtD
Cefdinir—Shock—Triamcinolone—psoriatic arthritis	0.00255	0.00255	CcSEcCtD
Cefdinir—Insomnia—Prednisolone—psoriatic arthritis	0.00255	0.00255	CcSEcCtD
Cefdinir—Shock—Methylprednisolone—psoriatic arthritis	0.00255	0.00255	CcSEcCtD
Cefdinir—Loss of consciousness—Betamethasone—psoriatic arthritis	0.00253	0.00253	CcSEcCtD
Cefdinir—Loss of consciousness—Dexamethasone—psoriatic arthritis	0.00253	0.00253	CcSEcCtD
Cefdinir—Agranulocytosis—Methotrexate—psoriatic arthritis	0.00251	0.00251	CcSEcCtD
Cefdinir—Convulsion—Dexamethasone—psoriatic arthritis	0.0025	0.0025	CcSEcCtD
Cefdinir—Convulsion—Betamethasone—psoriatic arthritis	0.0025	0.0025	CcSEcCtD
Cefdinir—Hypertension—Betamethasone—psoriatic arthritis	0.00249	0.00249	CcSEcCtD
Cefdinir—Hypertension—Dexamethasone—psoriatic arthritis	0.00249	0.00249	CcSEcCtD
Cefdinir—Haemoglobin—Methotrexate—psoriatic arthritis	0.00242	0.00242	CcSEcCtD
Cefdinir—Haemorrhage—Methotrexate—psoriatic arthritis	0.00241	0.00241	CcSEcCtD
Cefdinir—Anaphylactic shock—Dexamethasone—psoriatic arthritis	0.00235	0.00235	CcSEcCtD
Cefdinir—Anaphylactic shock—Betamethasone—psoriatic arthritis	0.00235	0.00235	CcSEcCtD
Cefdinir—Insomnia—Triamcinolone—psoriatic arthritis	0.00235	0.00235	CcSEcCtD
Cefdinir—Insomnia—Methylprednisolone—psoriatic arthritis	0.00234	0.00234	CcSEcCtD
Cefdinir—Shock—Betamethasone—psoriatic arthritis	0.00232	0.00232	CcSEcCtD
Cefdinir—Shock—Dexamethasone—psoriatic arthritis	0.00232	0.00232	CcSEcCtD
Cefdinir—Agitation—Prednisone—psoriatic arthritis	0.00231	0.00231	CcSEcCtD
Cefdinir—Thrombocytopenia—Dexamethasone—psoriatic arthritis	0.0023	0.0023	CcSEcCtD
Cefdinir—Thrombocytopenia—Betamethasone—psoriatic arthritis	0.0023	0.0023	CcSEcCtD
Cefdinir—Dyspepsia—Triamcinolone—psoriatic arthritis	0.00228	0.00228	CcSEcCtD
Cefdinir—Erythema multiforme—Methotrexate—psoriatic arthritis	0.00228	0.00228	CcSEcCtD
Cefdinir—Dyspepsia—Methylprednisolone—psoriatic arthritis	0.00228	0.00228	CcSEcCtD
Cefdinir—Anorexia—Betamethasone—psoriatic arthritis	0.00224	0.00224	CcSEcCtD
Cefdinir—Anorexia—Dexamethasone—psoriatic arthritis	0.00224	0.00224	CcSEcCtD
Cefdinir—Loss of consciousness—Prednisone—psoriatic arthritis	0.00221	0.00221	CcSEcCtD
Cefdinir—Convulsion—Prednisone—psoriatic arthritis	0.00218	0.00218	CcSEcCtD
Cefdinir—Hypertension—Prednisone—psoriatic arthritis	0.00217	0.00217	CcSEcCtD
Cefdinir—Insomnia—Betamethasone—psoriatic arthritis	0.00213	0.00213	CcSEcCtD
Cefdinir—Insomnia—Dexamethasone—psoriatic arthritis	0.00213	0.00213	CcSEcCtD
Cefdinir—Gastrointestinal pain—Methylprednisolone—psoriatic arthritis	0.00212	0.00212	CcSEcCtD
Cefdinir—Hypersensitivity—Prednisolone—psoriatic arthritis	0.00208	0.00208	CcSEcCtD
Cefdinir—Dyspepsia—Betamethasone—psoriatic arthritis	0.00207	0.00207	CcSEcCtD
Cefdinir—Dyspepsia—Dexamethasone—psoriatic arthritis	0.00207	0.00207	CcSEcCtD
Cefdinir—Body temperature increased—Triamcinolone—psoriatic arthritis	0.00205	0.00205	CcSEcCtD
Cefdinir—Anaphylactic shock—Prednisone—psoriatic arthritis	0.00205	0.00205	CcSEcCtD
Cefdinir—Abdominal pain—Methylprednisolone—psoriatic arthritis	0.00205	0.00205	CcSEcCtD
Cefdinir—Decreased appetite—Dexamethasone—psoriatic arthritis	0.00205	0.00205	CcSEcCtD
Cefdinir—Decreased appetite—Betamethasone—psoriatic arthritis	0.00205	0.00205	CcSEcCtD
Cefdinir—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	0.00203	0.00203	CcSEcCtD
Cefdinir—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	0.00203	0.00203	CcSEcCtD
Cefdinir—Shock—Prednisone—psoriatic arthritis	0.00202	0.00202	CcSEcCtD
Cefdinir—Anorexia—Prednisone—psoriatic arthritis	0.00195	0.00195	CcSEcCtD
Cefdinir—Gastrointestinal pain—Dexamethasone—psoriatic arthritis	0.00192	0.00192	CcSEcCtD
Cefdinir—Gastrointestinal pain—Betamethasone—psoriatic arthritis	0.00192	0.00192	CcSEcCtD
Cefdinir—Hypersensitivity—Triamcinolone—psoriatic arthritis	0.00191	0.00191	CcSEcCtD
Cefdinir—Hypersensitivity—Methylprednisolone—psoriatic arthritis	0.00191	0.00191	CcSEcCtD
Cefdinir—Leukopenia—Methotrexate—psoriatic arthritis	0.00188	0.00188	CcSEcCtD
Cefdinir—Dizziness—Prednisolone—psoriatic arthritis	0.00186	0.00186	CcSEcCtD
Cefdinir—Asthenia—Triamcinolone—psoriatic arthritis	0.00186	0.00186	CcSEcCtD
Cefdinir—Body temperature increased—Betamethasone—psoriatic arthritis	0.00186	0.00186	CcSEcCtD
Cefdinir—Abdominal pain—Dexamethasone—psoriatic arthritis	0.00186	0.00186	CcSEcCtD
Cefdinir—Abdominal pain—Betamethasone—psoriatic arthritis	0.00186	0.00186	CcSEcCtD
Cefdinir—Body temperature increased—Dexamethasone—psoriatic arthritis	0.00186	0.00186	CcSEcCtD
Cefdinir—Asthenia—Methylprednisolone—psoriatic arthritis	0.00186	0.00186	CcSEcCtD
Cefdinir—Insomnia—Prednisone—psoriatic arthritis	0.00185	0.00185	CcSEcCtD
Cefdinir—Pruritus—Triamcinolone—psoriatic arthritis	0.00183	0.00183	CcSEcCtD
Cefdinir—Pruritus—Methylprednisolone—psoriatic arthritis	0.00183	0.00183	CcSEcCtD
Cefdinir—Convulsion—Methotrexate—psoriatic arthritis	0.00182	0.00182	CcSEcCtD
Cefdinir—Dyspepsia—Prednisone—psoriatic arthritis	0.0018	0.0018	CcSEcCtD
Cefdinir—Chest pain—Methotrexate—psoriatic arthritis	0.00179	0.00179	CcSEcCtD
Cefdinir—Decreased appetite—Prednisone—psoriatic arthritis	0.00178	0.00178	CcSEcCtD
Cefdinir—Rash—Prednisolone—psoriatic arthritis	0.00178	0.00178	CcSEcCtD
Cefdinir—Dermatitis—Prednisolone—psoriatic arthritis	0.00178	0.00178	CcSEcCtD
Cefdinir—Diarrhoea—Methylprednisolone—psoriatic arthritis	0.00177	0.00177	CcSEcCtD
Cefdinir—Headache—Prednisolone—psoriatic arthritis	0.00177	0.00177	CcSEcCtD
Cefdinir—Constipation—Prednisone—psoriatic arthritis	0.00175	0.00175	CcSEcCtD
Cefdinir—Dizziness—Triamcinolone—psoriatic arthritis	0.00171	0.00171	CcSEcCtD
Cefdinir—Anaphylactic shock—Methotrexate—psoriatic arthritis	0.00171	0.00171	CcSEcCtD
Cefdinir—Dizziness—Methylprednisolone—psoriatic arthritis	0.00171	0.00171	CcSEcCtD
Cefdinir—Asthenia—Betamethasone—psoriatic arthritis	0.00169	0.00169	CcSEcCtD
Cefdinir—Asthenia—Dexamethasone—psoriatic arthritis	0.00169	0.00169	CcSEcCtD
Cefdinir—Thrombocytopenia—Methotrexate—psoriatic arthritis	0.00168	0.00168	CcSEcCtD
Cefdinir—Gastrointestinal pain—Prednisone—psoriatic arthritis	0.00168	0.00168	CcSEcCtD
Cefdinir—Nausea—Prednisolone—psoriatic arthritis	0.00168	0.00168	CcSEcCtD
Cefdinir—Pruritus—Dexamethasone—psoriatic arthritis	0.00166	0.00166	CcSEcCtD
Cefdinir—Pruritus—Betamethasone—psoriatic arthritis	0.00166	0.00166	CcSEcCtD
Cefdinir—Vomiting—Triamcinolone—psoriatic arthritis	0.00165	0.00165	CcSEcCtD
Cefdinir—Vomiting—Methylprednisolone—psoriatic arthritis	0.00165	0.00165	CcSEcCtD
Cefdinir—Rash—Triamcinolone—psoriatic arthritis	0.00164	0.00164	CcSEcCtD
Cefdinir—Dermatitis—Triamcinolone—psoriatic arthritis	0.00163	0.00163	CcSEcCtD
Cefdinir—Anorexia—Methotrexate—psoriatic arthritis	0.00163	0.00163	CcSEcCtD
Cefdinir—Rash—Methylprednisolone—psoriatic arthritis	0.00163	0.00163	CcSEcCtD
Cefdinir—Dermatitis—Methylprednisolone—psoriatic arthritis	0.00163	0.00163	CcSEcCtD
Cefdinir—Headache—Triamcinolone—psoriatic arthritis	0.00162	0.00162	CcSEcCtD
Cefdinir—Headache—Methylprednisolone—psoriatic arthritis	0.00162	0.00162	CcSEcCtD
Cefdinir—Abdominal pain—Prednisone—psoriatic arthritis	0.00162	0.00162	CcSEcCtD
Cefdinir—Body temperature increased—Prednisone—psoriatic arthritis	0.00162	0.00162	CcSEcCtD
Cefdinir—Diarrhoea—Betamethasone—psoriatic arthritis	0.00161	0.00161	CcSEcCtD
Cefdinir—Diarrhoea—Dexamethasone—psoriatic arthritis	0.00161	0.00161	CcSEcCtD
Cefdinir—Dizziness—Dexamethasone—psoriatic arthritis	0.00156	0.00156	CcSEcCtD
Cefdinir—Dizziness—Betamethasone—psoriatic arthritis	0.00156	0.00156	CcSEcCtD
Cefdinir—Insomnia—Methotrexate—psoriatic arthritis	0.00155	0.00155	CcSEcCtD
Cefdinir—Nausea—Triamcinolone—psoriatic arthritis	0.00154	0.00154	CcSEcCtD
Cefdinir—Nausea—Methylprednisolone—psoriatic arthritis	0.00154	0.00154	CcSEcCtD
Cefdinir—Somnolence—Methotrexate—psoriatic arthritis	0.00152	0.00152	CcSEcCtD
Cefdinir—Hypersensitivity—Prednisone—psoriatic arthritis	0.00151	0.00151	CcSEcCtD
Cefdinir—Dyspepsia—Methotrexate—psoriatic arthritis	0.00151	0.00151	CcSEcCtD
Cefdinir—Vomiting—Dexamethasone—psoriatic arthritis	0.0015	0.0015	CcSEcCtD
Cefdinir—Vomiting—Betamethasone—psoriatic arthritis	0.0015	0.0015	CcSEcCtD
Cefdinir—Decreased appetite—Methotrexate—psoriatic arthritis	0.00149	0.00149	CcSEcCtD
Cefdinir—Rash—Dexamethasone—psoriatic arthritis	0.00148	0.00148	CcSEcCtD
Cefdinir—Rash—Betamethasone—psoriatic arthritis	0.00148	0.00148	CcSEcCtD
Cefdinir—Dermatitis—Betamethasone—psoriatic arthritis	0.00148	0.00148	CcSEcCtD
Cefdinir—Dermatitis—Dexamethasone—psoriatic arthritis	0.00148	0.00148	CcSEcCtD
Cefdinir—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	0.00148	0.00148	CcSEcCtD
Cefdinir—Headache—Betamethasone—psoriatic arthritis	0.00147	0.00147	CcSEcCtD
Cefdinir—Headache—Dexamethasone—psoriatic arthritis	0.00147	0.00147	CcSEcCtD
Cefdinir—Asthenia—Prednisone—psoriatic arthritis	0.00147	0.00147	CcSEcCtD
Cefdinir—Pruritus—Prednisone—psoriatic arthritis	0.00145	0.00145	CcSEcCtD
Cefdinir—Diarrhoea—Prednisone—psoriatic arthritis	0.0014	0.0014	CcSEcCtD
Cefdinir—Gastrointestinal pain—Methotrexate—psoriatic arthritis	0.0014	0.0014	CcSEcCtD
Cefdinir—Nausea—Betamethasone—psoriatic arthritis	0.0014	0.0014	CcSEcCtD
Cefdinir—Nausea—Dexamethasone—psoriatic arthritis	0.0014	0.0014	CcSEcCtD
Cefdinir—Dizziness—Prednisone—psoriatic arthritis	0.00136	0.00136	CcSEcCtD
Cefdinir—Abdominal pain—Methotrexate—psoriatic arthritis	0.00135	0.00135	CcSEcCtD
Cefdinir—Body temperature increased—Methotrexate—psoriatic arthritis	0.00135	0.00135	CcSEcCtD
Cefdinir—Vomiting—Prednisone—psoriatic arthritis	0.0013	0.0013	CcSEcCtD
Cefdinir—Rash—Prednisone—psoriatic arthritis	0.00129	0.00129	CcSEcCtD
Cefdinir—Dermatitis—Prednisone—psoriatic arthritis	0.00129	0.00129	CcSEcCtD
Cefdinir—Headache—Prednisone—psoriatic arthritis	0.00128	0.00128	CcSEcCtD
Cefdinir—Hypersensitivity—Methotrexate—psoriatic arthritis	0.00126	0.00126	CcSEcCtD
Cefdinir—Asthenia—Methotrexate—psoriatic arthritis	0.00123	0.00123	CcSEcCtD
Cefdinir—Nausea—Prednisone—psoriatic arthritis	0.00122	0.00122	CcSEcCtD
Cefdinir—Pruritus—Methotrexate—psoriatic arthritis	0.00121	0.00121	CcSEcCtD
Cefdinir—Diarrhoea—Methotrexate—psoriatic arthritis	0.00117	0.00117	CcSEcCtD
Cefdinir—Dizziness—Methotrexate—psoriatic arthritis	0.00113	0.00113	CcSEcCtD
Cefdinir—Vomiting—Methotrexate—psoriatic arthritis	0.00109	0.00109	CcSEcCtD
Cefdinir—Rash—Methotrexate—psoriatic arthritis	0.00108	0.00108	CcSEcCtD
Cefdinir—Dermatitis—Methotrexate—psoriatic arthritis	0.00108	0.00108	CcSEcCtD
Cefdinir—Headache—Methotrexate—psoriatic arthritis	0.00107	0.00107	CcSEcCtD
Cefdinir—Nausea—Methotrexate—psoriatic arthritis	0.00102	0.00102	CcSEcCtD
